JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF) Short Interest Update

JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF) was the recipient of a large drop in short interest during the month of March. As of March 15th, there was short interest totalling 168,500 shares, a drop of 44.8% from the February 28th total of 305,100 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is presently ∞ days.

JCR Pharmaceuticals Stock Performance

OTCMKTS:JCRRF remained flat at $4.57 during trading hours on Friday. The stock’s 50 day moving average is $4.57 and its 200 day moving average is $4.59. JCR Pharmaceuticals has a fifty-two week low of $4.30 and a fifty-two week high of $4.70.

About JCR Pharmaceuticals

JCR Pharmaceuticals Co, Ltd., together with its subsidiaries, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V.